Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US-Reference-Cited by-同舟云学术

Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US

Published:2015-12 Issue:1 Volume:4 Page:
ISSN:2162-3619
Container-title:Experimental Hematology & Oncology
language:en
Short-container-title:Exp Hematol Oncol

Author:

Xie Jipan,Hao Yanni,Li Nanxin,Lin Peggy L.,Ohashi Erika,Koo Valerie,Wu Eric Q.

Funder

Novartis Pharmaceuticals Corporation (US)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s40164-015-0023-0

Reference39 articles.

1. International Agency for Research on Cancer, Cancer Research UK. World cancer factsheet. Cancer Research UK, London, UK. 2014. http://publications.cancerresearchuk.org/downloads/Product/CS_REPORT_WORLD.pdf . Accessed 21 May 2015.

2. National Cancer Institute. SEER Cancer Statistics Factsheets: Breast Cancer. National Cancer Institute, Bethesda, MD. 2014. http://seer.cancer.gov/statfacts/html/breast.html . Accessed 21 May 2015.

3. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1–22.

4. Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271–7. doi: 10.1200/JCO.2009.25.9820 .

5. Cadoo KA, Fornier MN, Morris PG. Biological subtypes of breast cancer: current concepts and implications for recurrence patterns. Q J Nucl Med Mol Imaging. 2013;57(4):312–21.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score;Breast Cancer Research and Treatment;2023-03-14

2. Survival Benefit of Surgical Treatment Added Into Systemic Treatment for Isolated Breast Cancer Liver Metastases: A Systematic Review and Meta-Analysis;Frontiers in Surgery;2021-10-25

3. Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review;Cancer Management and Research;2021-08

4. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients;BMC Cancer;2021-04-29

5. The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice;Critical Reviews in Oncology/Hematology;2020-09